Status:
COMPLETED
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Lead Sponsor:
State University of New York at Buffalo
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Conditions:
Opiate Addiction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.
Detailed Description
The purpose of this randomized clinical trial is to compare methadone with buprenorphine for the treatment of chronic pain among patients who have developed a physical dependence on prescription opiat...
Eligibility Criteria
Inclusion
- chronic back pain
- opioid addiction
- not successful with abstinence
- at least 18 years old
- able to understand spoken English
- live in Western New York State (Erie or Niagara county)
- have health insurance or ability to pay for health care
- no methadone or buprenorphine treatment within past year
- not member of a vulnerable population (e.g., pregnancy, prisoner)
Exclusion
- homelessness
- unable to give consent (e.g., dementia, psychosis)
- serious heart or lung disease
- taking a medication that could interact with methadone or buprenorphine
- pregnancy
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00879996
Start Date
April 1 2009
End Date
October 1 2011
Last Update
August 7 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheehan Memorial Hospital
Buffalo, New York, United States, 14203
2
Erie County Medical Center
Buffalo, New York, United States, 14215